(S (NP (EX There)) (VP (VBZ has) (VP (VBN been) (NP (NP (DT a) (JJ steady) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NN skin) (NN cancer)))))) (PP (ADVP (RB worldwide)) (, ,) (IN with) (NP (NP (DT a) (JJ high) (NN rate)) (PP (IN of) (NP (NN mortality))))))) (. .))
(S (NP (NP (RB Early) (NN detection) (CC and) (NN segmentation)) (PP (IN of) (NP (NN skin) (NNS lesions)))) (VP (VBP are) (ADJP (JJ crucial) (PP (IN for) (NP (JJ timely) (NN diagnosis) (CC and) (NN treatment)))) (, ,) (S (ADJP (JJ necessary) (S (VP (TO to) (VP (VB improve) (NP (NP (DT the) (NN survival) (NN rate)) (PP (IN of) (NP (NNS patients)))))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (NN skin) (NN lesion) (NN segmentation)) (VP (VBZ is) (NP (DT a) (JJ challenging) (NN task)) (PP (IN due) (PP (IN to) (NP (NP (NP (DT the) (JJ low) (NN contrast)) (PP (IN of) (NP (NNS lesions)))) (CC and) (NP (NP (PRP$ their) (JJ high) (NN similarity)) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NN appearance))))))))) (, ,) (PP (IN to) (NP (JJ healthy) (NN tissue)))) (. .))
(S (NP (DT This)) (VP (VBZ underlines) (NP (NP (DT the) (NN need)) (PP (IN for) (NP (NP (DT an) (ADJP (JJ accurate) (CC and) (JJ automatic)) (NN approach)) (PP (IN for) (NP (NN skin) (NN lesion) (NN segmentation))))))) (. .))
(S (S (VP (TO To) (VP (VB tackle) (NP (DT this) (NN issue))))) (, ,) (NP (PRP we)) (VP (VBP propose) (NP (NP (NP (DT a) (JJ convolutional) (JJ neural) (NN network)) (-LRB- -LRB-) (NP (NNP CNN)) (-RRB- -RRB-)) (VP (VBN called) (NP (NNP SkinNet))))) (. .))
(S (NP (DT The) (VBN proposed) (NNP CNN)) (VP (VBZ is) (NP (NP (DT a) (VBN modified) (NN version)) (PP (IN of) (NP (NNP U-Net))))) (. .))
(S (NP (PRP We)) (VP (VBD compared) (NP (NP (DT the) (NN performance)) (PP (IN of) (NP (PRP$ our) (NN approach)))) (PP (IN with) (NP (JJ other) (NML (NML (NN state)) (HYPH -) (PP (IN of) (HYPH -) (NP (DT the) (HYPH -) (NN art)))) (NNS techniques))) (, ,) (S (VP (VBG using) (NP (DT the) (NNP ISBI) (NML (CD 2017) (NN challenge)) (NN dataset))))) (. .))
(S (NP (PRP$ Our) (NN approach)) (VP (VBD outperformed) (NP (NP (DT the) (NNS others)) (PP (IN in) (NP (NP (NP (NNS terms)) (PP (IN of) (NP (NP (DT the) (NN Dice) (NN coefficient)) (, ,) (NP (NNP Jaccard) (NN index)) (CC and) (NP (NN sensitivity))))) (, ,) (VP (VBN evaluated) (PP (IN on) (NP (NP (DT the) (ADJP (VBN held) (HYPH -) (RP out)) (NN challenge) (NN test) (NNS data)) (VP (VBN set))))) (, ,)))) (PP (IN across) (NP (NP (RB 5-fold) (JJ cross) (NN validation)) (NP (NNS experiments))))) (. .))
(S (NP (NNP SkinNet)) (VP (VBD achieved) (NP (NP (DT an) (JJ average) (NN value)) (PP (IN of) (NP (NP (CD 85.10)) (, ,) (NP (QP (CD 76.67) (CC and) (CD 93.0)) (NN %)) (, ,)))) (PP (IN for) (NP (DT the) (NNP DC) (, ,) (NNP JI) (, ,) (CC and) (NNP SE))) (, ,) (ADVP (RB respectively))) (. .))
